
浏览全部资源
扫码关注微信
天津市中医药研究院 附属医院,天津 300120
蔚志仁,硕士,主治医师,从事皮肤与性病临床和诊断研究,Tel: 022-27285203,E-mail: yu-zhiren@163.com
张宇,博士,主任医师,从事皮肤真菌感染性疾病研究,Tel:022-27345050,E-mail: niuniuzy@aliyun.com
收稿日期:2018-07-24,
网络出版日期:2018-11-16,
纸质出版日期:2019-03-05
移动端阅览
蔚志仁, 石晶, 王彩霞, 等. 参苓白术散加减治疗脾虚湿蕴型亚急性湿疹临床疗效及对炎症因子和外周血T淋巴细胞亚群的影响[J]. 中国实验方剂学杂志, 2019,25(5):63-67.
Zhi-ren YU, Jing SHI, Cai-xia WANG, et al. Effect of Modified Shenling Baizhu San on Inflammatory Factors and Peripheral Blood T Lymphocyte Subsets in Spleen Deficiency Wetness Type Subacute Eczema[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(5): 63-67.
蔚志仁, 石晶, 王彩霞, 等. 参苓白术散加减治疗脾虚湿蕴型亚急性湿疹临床疗效及对炎症因子和外周血T淋巴细胞亚群的影响[J]. 中国实验方剂学杂志, 2019,25(5):63-67. DOI: 10.13422/j.cnki.syfjx.20190330.
Zhi-ren YU, Jing SHI, Cai-xia WANG, et al. Effect of Modified Shenling Baizhu San on Inflammatory Factors and Peripheral Blood T Lymphocyte Subsets in Spleen Deficiency Wetness Type Subacute Eczema[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(5): 63-67. DOI: 10.13422/j.cnki.syfjx.20190330.
目的:
2
观察参苓白术散加减治疗脾虚型亚急性湿疹患者的临床疗效,研究其对炎症因子和外周血T淋巴细胞亚群的影响,为临床治疗提供理论依据。
方法:
2
选取本院2016年1月至2017年12月诊治的176例脾虚湿蕴型湿疹患者作为研究对象,随机分为对照组(88例)和观察组(88例),对照组给予盐酸左西替利嗪片和复方硝酸益康唑凝胶治疗,观察组在对照组的基础上给予参苓白术散加减,治疗4周。观察两组患者临床疗效、治疗前后瘙痒评分、严重度指数(severity index
EASI)评分、皮肤病生活质量表(dermatology quality of life scales
DQOLS)评分、炎症因子及外周血T淋巴细胞亚群水平变化情况;随访6个月观察患者的复发情况。
结果:
2
治疗后,观察组患者瘙痒评分和EASI评分较本组治疗前降低,且观察组明显低于对照组(
P
<
0.05);DQOLS评分较本组治疗前升高,且观察组明显高于对照组(
P
<
0.05)。观察组患者临床有效率明显高于对照组(
P
<
0.05)。治疗后,观察组患者白细胞介素(interleukins
IL)-1
β
,IL-2,IL-4,IL-5,肿瘤坏死因子(tumor necrosis factor
TNF)-
α
水平较本组治疗前降低,且观察组明显低于对照组(
P
<
0.05);两组CD4
+
,CD4
+
/CD8
+
水平较本组治疗前升高,且观察组明显高于对照组(
P
<
0.05)。随访6个月,观察组患者复发率明显低于对照组(
P
<
0.05)。
结论:
2
参苓白术散加减通过抑制患者炎症反应,增强免疫功能,从而提高临床疗效。
Objective:
2
To observe the clinical efficacy modified Shenling Baizhu San in treating patients with spleen deficiency wetness type subacute eczema
and its effect on the inflammatory factors and peripheral blood T lymphocyte subsets
so as to provide a theoretical basis for clinical treatment.
Method:
2
Totally 176 cases of spleen deficiency wetness type subacute eczema treated at our hospital from Jan. 2016 to Dec. 2017 were selected and randomly divided into control group (88 cases) and observation group (88 cases). Control group was treated with levocetirizine hydrochloride tablets and compound econazole nitrate gel
and observation group was given modified Shenling Baizhu San in addition to therapy of control group for 4 weeks. The clinical efficacy
pruritus score
severity index(EASI)score
dermatology quality of life scales(DQOLS) score and recurrence rate were observed
and inflammatory factor and peripheral blood T lymphocyte subgroup level were detected.
Result:
2
After treatment
the pruritus score and EASI score in observation group were lower than those before treatment (
P
<
0.05)
and those of observation group were significantly lower than those of control group (
P
<
0.05). However
the DQOLS score was higher than that before treatment
and significantly higher than that of control group (
P
<
0.05). The clinical effective rate of observation group was significantly higher than that of control group (
P
<
0.05). After treatment
the levels of interleukins(IL)-1
β
IL-2
IL-4
IL-5 and tumor necrosis factor(TNF)-
α
in observation group were lower than those before treatment (
P
<
0.05)
and the levels of CD4
+
and CD4
+
/CD8
+
were higher than those of before treatment
and significantly higher than those of control group (
P
<
0.05). During the 6-month follow-up
the recurrence rate of observation group was significantly lower than that of control group (
P
<
0.05).
Conclusion:
2
Modified Shenling Baizhu San could enhance the clinical efficacy by inhibiting the inflammatory reaction and regulating the immune function of patients.
Fischer A H , Shin D B , Margolis D J , et al . Racial and ethnic differences in health care utilization for childhood eczema: an analysis of the 2001-2013 medical expenditure panel surveys [J]. J Am Acad Dermatol , 2017 , 77 ( 6 ): 1060 - 1067 .
Lubbes S , Rustemeyer T , Sillevis S J , et al . Contact sensitization in Dutch children and adolescents with and without atopic dermatitis-a retrospective analysis [J]. Contact Dermatitis , 2017 , 76 ( 3 ): 151 - 159 .
CAI J , LIU W , HU Y , et al . Household environment, lifestyle behaviors, and dietary habits in relation to childhood atopic eczema in Shanghai, China [J]. Int Arch Occup Environ Health , 2017 , 90 ( 1 ): 141 - 159 .
Baron S E , Cohen S N , Archer C B. Guidance on the diagnosis and clinical management of atopic eczema [J]. Clin Exp Dermatol , 2012 , 37 ( Suppl 1 ): 7 - 12 .
贾淑青 , 方锐华 . 复方苦参水酊剂治疗亚急性湿疹临床观察 [J]. 中国民族民间医药 , 2017 , 26 ( 14 ): 101 - 103 .
孙志高 , 路军章 , 周杉京 , 等 . 中医药治疗湿疹的研究进展 [J]. 中华中医药杂志 , 2017 , 32 ( 8 ): 3617 - 3619 .
董琦然 , 张虹亚 . 湿疹的中医治疗研究简况 [J]. 中医药临床杂志 , 2018 , 30 ( 3 ): 568 - 572 .
Mooney E , Rademaker M , Dailey R , et al . Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement [J]. Australas J Dermatol , 2015 , 56 ( 4 ): 241 - 251 .
中华医学会皮肤性病学分会免疫学组 . 湿疹诊疗指南(2011年) [J]. 中华皮肤科杂志 , 2011 , 44 ( 1 ): 5 - 6 .
中华人民共和国卫生部 . 中药新药临床研究指导原则 [M]. 北京 : 中国医药科技出版社 , 2002 : 295 - 298 .
许文 , 冯爱民 , 周红 , 等 . 糠酸莫米松乳膏联合卡泊三醇软膏治疗慢性湿疹及神经性皮炎的效果 [J]. 广东医学 , 2015 , 36 ( 1 ): 130 - 132 .
王媛 , 张建国 . 润燥止痒胶囊治疗慢性湿疹40例临床观察 [J]. 中医药导报 , 2017 , 23 ( 20 ): 103 - 105 .
岳智浩 , 伊九 , 闫泽灏 , 等 . 枸地氯雷他定联合复方甘草酸苷治疗亚急性湿疹疗效观察 [J]. 人民军医 , 2017 , 60 ( 4 ): 381 - 384 .
吕宏梅 , 王旭英 , 王巧伟 , 等 . 北京市空气污染对湿疹患者门诊量影响的时间序列研究 [J]. 临床皮肤科杂志 , 2016 , 45 ( 5 ): 328 - 331 .
刘岳花 , 卢凤艳 . 手部湿疹的病因与治疗研究现状 [J]. 皮肤病与性病 , 2017 , 39 ( 4 ): 261 - 263 .
Sheikhi A , Giti H , Heibor M R , et al . Lactobacilus delbrueckii subsp. Bulgaricus modulates the secretion of Th1/Th2 and treg cell-related cytokines by PBMCs from patients with atopic dermatitis [J]. Drug Res (Stuttg) , 2017 , 67 ( 12 ): 724 - 729 .
梁伟海 , 黄鹏 , 李伦 , 等 . 苦桉祛疹凝胶对大鼠湿疹模型的影响 [J]. 中国实验方剂学杂志 , 2016 , 22 ( 13 ): 97 - 101 .
王小勇 , 陶承军 , 应航宇 , 等 . 自制止痒湿疹合剂治疗慢性湿疹疗效及对血清IL-1、IL-2、IL-6水平的影响 [J]. 中国中西医结合皮肤性病学杂志 , 2016 , 15 ( 4 ): 221 - 224 .
刘惠知 , 吴胜莲 , 张德元 , 等 . 茯苓药物成分提取分离及其药用价值研究进展 [J]. 中国食用菌 , 2015 , 34 ( 6 ): 1 - 6 .
孙志欣 , 陈莉 , 李锐 , 等 . 参苓白术散对老年社区获得性肺炎肺脾气虚证患者血清炎症因子及免疫功能的影响 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 21 ): 161 - 165 .
Funakoshi-Tago M , Tanabe S , Tago K , et al . Licochalcone A potently inhibits tumor necrosis factor alpha-induced nuclear factorkappa Bactivation through the direct inhibition of Ikappa B kinase complex activation [J]. Mol Pharmacol , 2009 , 76 ( 4 ): 745 - 753 .
戴应和 , 龙小琴 , 张娟 , 等 . 甘草黄酮的抗炎作用及其机制的研究进展 [J]. 江西中医药 , 2017 , 48 ( 2 ): 68 - 71 .
WANG C H , DUAN H J , HE L C. Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro [J]. Eur J Pharmacol , 2009 , 612 ( 1/3 ): 143 - 152 .
吴科锐 , 韩凌 . 羧甲基茯苓多糖药理作用研究进展 [J]. 中药材 , 2017 , 40 ( 3 ): 744 - 747 .
朱晓玉 , 刘雄 , 高建德 , 等 . 党参多糖药理作用及其提取方法研究进展 [J]. 甘肃中医药大学学报 , 2016 , 33 ( 6 ): 77 - 79 .
王新绘 , 李金耀 , 刘晓颖 , 等 . 甘草及其有效成分对免疫系统调节作用研究进展 [J]. 中成药 , 2016 , 38 ( 2 ): 392 - 395 .
0
浏览量
18
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621